x
Filter:
Filters applied
- ACMG Statements and Guidelines
- May - November 2022Remove May - November 2022 filter
- Genetics in MedicineRemove Genetics in Medicine filter
Author
- Abul-Husn, Noura S1
- Aiyar, Lila1
- Amendola, Laura M1
- Brothers, Kyle1
- Chung, Wendy K1
- Dinulos, Mary Beth1
- Flannery, David1
- Gollob, Michael H1
- Gordon, Adam S1
- Harrison, Steven M1
- Hershberger, Ray E1
- Klein, Teri E1
- Lee, Kristy1
- Lloyd-Puryear, Michele A1
- Martin, Christa Lese1
- McClure, Michelle L1
- Miller, David T1
- Richards, Carolyn Sue1
- Sanghavi, Kunal1
- Stewart, Douglas R1
- Trotter, Tracy L1
- Viskochil, David1
- Williams, Heather E1
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
2 Results
- ACMG Statement
Considerations for policymakers for improving health care through telegenetics: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 24Issue 11p2211–2219Published online: August 30, 2022- Heather E. Williams
- Lila Aiyar
- Mary Beth Dinulos
- David Flannery
- Michelle L. McClure
- Michele A. Lloyd-Puryear
- and others
Cited in Scopus: 0Telegenetics, a form of telemedicine, is 2-way, interactive real-time electronic information communication between a patient and genetics health care professional(s) (ie, medical geneticists [physicians who specialize in genetics] and genetic counselors [health care workers with training in medical genetics and counseling]) as an alternate to providing health care in person at a medical office.1,2 These services include, but are not limited to, assessment, diagnosis, consultation, test result release, education, counseling, management of care, and/or aided self-management. - ACMG Statement
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 24Issue 7p1407–1414Published online: June 17, 2022- David T. Miller
- Kristy Lee
- Noura S. Abul-Husn
- Laura M. Amendola
- Kyle Brothers
- Wendy K. Chung
- and others
Cited in Scopus: 21The American College of Medical Genetics and Genomics (ACMG) previously published guidance for reporting secondary findings (SF) in the context of clinical exome and genome sequencing in 2013, 2017, and 2021.1-3 The ACMG Secondary Findings Working Group (SFWG) and Board of Directors (BOD) have agreed that the list of recommended genes should now be updated annually, but with an ongoing goal of maintaining this as a minimum list. Reporting of SF should be considered neither a replacement for indication-based diagnostic clinical genetic testing nor a form of population screening.
